FTC’s NxStage/Fresenius Review Remains In Info Gathering Mode

Five months into a second request from the U.S. Federal Trade Commission, NxStage and Fresenius are in the “middle of things” with the regulatory agency, anfeatured

CTFN First Look: Stewart Information Services-Fidelity National Financial

On March 19, Fidelity National Financial announced a $1.2 billion acquisition of rival Stewart Information Services. The per share consideration is $25 in cash and 0.6425 common sharesfeatured

DOJ Meeting with Monsanto and Bayer Shows Serious Concerns Continue

Antitrust sources told CTFN that recent meetings between the leadership of the antitrust division of the Department of Justice and executives of Bayer andfeatured

Broadcom’s Efforts to Ease CFIUS Concerns Could Fall Short

Broadcom’s March 9 letter to Congress, in which it pledges to make the U.S. the global leader in 5G and in which it aims to address “misconceptions” regarding a Qualcomm combination, will havefeatured

CTFN First Look: Express Scripts-Cigna

On March 8, health insurer Cigna announced a $67 billion acquisition of pharmacy benefits manager Express Scripts. The per share offer consideration consists of $48.75 in cash and 0.2434 shares of stock in the combined company. Closing guidance is for the end of the year, subject to shareholderfeatured

Bayer Still Facing Questions from DOJ on Divestiture Plan for Monsanto Acquisition

With additional reporting by Rachel Rigby – As Bayer seeks to conclude the U.S. antitrust review of its acquisition of Monsanto, questions from staff attorneys in the antitrust division offeatured

360b / Shutterstock.com

Spectrum’s Sale of Rayovac to Energizer Likely Draws 2nd Request from FTC

Energizer’s $2 billion acquisition of Spectrum Brands’ battery business will likely draw a second request from the Federal Trade Commission, a person close to the matter told CTFN.featured

More Conservative DOJ Upends Expectations

With additional reporting by Rachel Rigby – Former attorneys in the Department of Justice’s antitrust division expressed surprise over patterns that appear to be developing within the division and how it is being managedfeatured

Fresenius and Akorn Look Set to Square Off

With additional reporting by Valeria Camerino – Fresenius announced on February 26 that it was “conducting an independent investigation, using external experts, into alleged breaches of FDA data integrityfeatured

Mofcom Approval of NXP/Qualcomm Likely Within Weeks

With additional reporting by Mingjie Wang – An approval from China’s Ministry of Commerce regarding Qualcomm’s acquisition of NXP Semiconductors is expectedfeatured


Interested in a trial?

Simply fill out the form below and one of our representatives will be in touch.